S'abonner

Identification and analysis of peanut-specific effector T and regulatory T cells in children allergic and tolerant to peanut - 04/05/18

Doi : 10.1016/j.jaci.2018.01.035 
Katherine A. Weissler, PhD a, Marjohn Rasooly, MSN a, Tom DiMaggio, BSN a, Hyejeong Bolan, MSN a, Daly Cantave, MSN a, David Martino, PhD b, c, Melanie R. Neeland, PhD b, Mimi L.K. Tang, MD, PhD b, c, d, Thanh D. Dang, PhD b, c, Katrina J. Allen, MD, PhD b, c, d, Pamela A. Frischmeyer-Guerrerio, MD, PhD a,
a Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Md 
b Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Australia 
d Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia 
c Department of Pediatrics, University of Melbourne, Melbourne, Australia 

Corresponding author: Pamela A. Frischmeyer-Guerrerio, MD, PhD, BG 10 RM 11N240B MSC 1889, 10 Center Dr, Bethesda, MD 20892.BG 10 RM 11N240B MSC 188910 Center DrBethesdaMD20892

Abstract

Background

Peanut allergy (PA) is potentially life-threatening and generally persists for life. Recent data suggest the skin might be an important route of initial sensitization to peanut, whereas early oral exposure to peanut is protective. In mice regulatory T (Treg) cells are central to the development of food tolerance, but their contribution to the pathogenesis of food allergy in human subjects is less clear.

Objective

We sought to quantify and phenotype CD4+ peanut-specific effector T (ps-Teff) cells and peanut-specific regulatory T (ps-Treg) cells in children with and without PA or PS.

Methods

ps-Teff and ps-Treg cells were identified from peripheral blood of children with PA, children with PS, and nonsensitized/nonallergic (NA) school-aged children and 1-year-old infants based on upregulation of CD154 or CD137, respectively, after stimulation with peanut extract. Expression of cytokines and homing receptors was evaluated by using flow cytometry. Methylation at the forkhead box protein 3 (FOXP3) locus was measured as a marker of Treg cell stability.

Results

Differential upregulation of CD154 and CD137 efficiently distinguished ps-Teff and ps-Treg cells. A greater percentage of ps-Teff cells from infants with PA and infants with PS expressed the skin-homing molecule cutaneous lymphocyte antigen, suggesting activation after exposure through the skin, compared with NA infants. Although ps-Teff cells in both school-aged and infant children with PA produced primarily TH2 cytokines, a TH1-skewed antipeanut response was seen only in NA school-aged children. The frequency, homing receptor expression, and stability of ps-Treg cells in infants and school-aged children were similar, regardless of allergic status.

Conclusions

Exposure to peanut through the skin can prime the development of TH2 ps-Teff cells, which promote sensitization to peanut, despite the presence of normal numbers of ps-Treg cells.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : Peanut allergy, regulatory T, antigen specificity, CD154, CD137, cutaneous lymphocyte antigen, α4β7, route of sensitization, food allergy

Abbreviations used : CLA, CPE, FOXP3, IQR, NA, NIH, OFC, PA, PS, ps-Teff, ps-Treg, SPT, Treg


Plan


 Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
 Disclosure of potential conflict of interest: K. A. Weissler received travel reimbursement from the American Academy of Allergy, Asthma & Immunology (AAAAI). M. L. K. Tang received board membership from Nestle Nutrition Institute and Danone Nutricia; received consultancy fees from Deerfield Consulting, GLG consulting, and Bayer; and is employed by Prota Therapeutics, and her the institution received grants from National Health and Medical Research Council Australia and Prota Therapeutics; payment for lectures from Danone Nutricia and Nestle Health Sciences; patents from Murdoch Childrens research Institute; royalties from Wilkinson Publishing; payment from development of educational presentations from MD Linx; and stock options from Prota Therapeutics. K. J. Allen received consultancy fees from Before Brands. P. A. Frischmeyer-Guerrerio received travel expenses from AAAAI, the European Academy of Allergy and Clinical Immunology, Thermo Fisher, Murdoch Children's Research Institute, University of Virginia, and Northwestern University. The rest of the authors declare that they have no relevant conflict of interests.


© 2018  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 141 - N° 5

P. 1699 - mai 2018 Retour au numéro
Article précédent Article précédent
  • Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci
  • Lisa J. Martin, Hua He, Margaret H. Collins, J.Pablo Abonia, Joceyln M. Biagini Myers, Michael Eby, Hanna Johansson, Leah C. Kottyan, Gurjit K. Khurana Hershey, Marc E. Rothenberg
| Article suivant Article suivant
  • Mechanism for initiation of food allergy: Dependence on skin barrier mutations and environmental allergen costimulation
  • Matthew T. Walker, Jeremy E. Green, Ryan P. Ferrie, Ashley M. Queener, Mark H. Kaplan, Joan M. Cook-Mills

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.